SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10743799
Source:
http://linkedlifedata.com/resource/pubmed/id/10743799
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003873
,
umls-concept:C0020336
,
umls-concept:C0087111
,
umls-concept:C0205421
,
umls-concept:C0439234
,
umls-concept:C0450442
,
umls-concept:C0686907
,
umls-concept:C1522577
,
umls-concept:C2603343
pubmed:issue
3
pubmed:dateCreated
2000-5-9
pubmed:abstractText
To assess the longterm effect of delaying therapy with second-line agents in patients with early rheumatoid arthritis (RA).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7501984
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxychloroquine
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0315-162X
pubmed:author
pubmed-author:BombardierCC
,
pubmed-author:CividinoAA
,
pubmed-author:EsdaileJ MJM
,
pubmed-author:FitzcharlesM AMA
,
pubmed-author:FitzgeraldA AAA
,
pubmed-author:JosephLL
,
pubmed-author:M'SeffarAA
,
pubmed-author:ThorneJ CJC
,
pubmed-author:TsakonasEE
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
623-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10743799-Adult
,
pubmed-meshheading:10743799-Aged
,
pubmed-meshheading:10743799-Antirheumatic Agents
,
pubmed-meshheading:10743799-Arthritis, Rheumatoid
,
pubmed-meshheading:10743799-Disability Evaluation
,
pubmed-meshheading:10743799-Female
,
pubmed-meshheading:10743799-Follow-Up Studies
,
pubmed-meshheading:10743799-Health Status
,
pubmed-meshheading:10743799-Humans
,
pubmed-meshheading:10743799-Hydroxychloroquine
,
pubmed-meshheading:10743799-Male
,
pubmed-meshheading:10743799-Middle Aged
,
pubmed-meshheading:10743799-Prospective Studies
,
pubmed-meshheading:10743799-Questionnaires
,
pubmed-meshheading:10743799-Randomized Controlled Trials as Topic
,
pubmed-meshheading:10743799-Sickness Impact Profile
,
pubmed-meshheading:10743799-Time Factors
pubmed:year
2000
pubmed:articleTitle
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
pubmed:affiliation
Department of Medicine, McGill University, Montreal, Quebec, Canada.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't